The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2022 | Addressing challenges in lung cancer screening
Rachael Murray, PhD, University of Nottingham, Nottingham, UK, comments on issues relating to lung cancer screening, including recruitment issues in people from a lower socioeconomic background and who are smokers. These group of people are often most at risk of developing lung cancer and hence need to be screened more to receive the appropriate treatment if needed. This interview took place at the 20th Annual British Thoracic Oncology Group (BTOG) Conference 2022.
